Start-ups in Europe have traditionally found it more difficult than those in the USA to secure growth capital. Venture capital companies are of course key in thisStart-ups in Europe have traditionally found it more difficult than those in the USA to secure growth capital. Venture capital companies are of course key in this

DN Capital: A quiet Architect of European Unicorns

2025/12/22 18:11
4 min read

Start-ups in Europe have traditionally found it more difficult than those in the USA to secure growth capital. Venture capital companies are of course key in this process – but investment by itself isn’t enough. 

The longest-lasting and most successful VC players such as DN Capital rely on a strong combination of capital, expertise and a strong network that they bring into their support for the startups they invest in at the earliest stages. 

The company’s portfolio paints the picture: over 60 successful exits show that the DN Capital strategy works. But what exactly is the approach that turns promising European start-ups into unicorns?

Capital alone is not enough – what firms like DN Capital do differently

DN Capital was founded in 2000 by Nenad Marovac and Steve Schlenker and has since established itself as one of the leading European venture capital providers

With offices in London, Berlin and Menlo Park, the company focuses on seed and Series A investments in the areas of FinTech, B2B software, marketplaces and digital health solutions. DN Capital’s approach goes beyond the provision of capital:

  • Operational support: Active support for portfolio companies through board seats and strategic advice
  • Network access: arranging contacts with potential customers, partners, key strategic hires and follow-on investors

DN Capital deliberately pursues a thesis-driven investment approach: instead of reacting to short-term trends, the team identifies long-term developments such as in of agentic enterprise AI, core banking software or consumer technologies like education or marketplaces.  

From the seed phase to the unicorn-tier exit: staying power as a success factor

DN Capital is known for closely supporting portfolio companies over many years – even in phases when other investors would have long since exited or forced a sale:

  • Endeca: Sale of the e-commerce tech pioneer to Oracle in 2011 for over 1 billion USD; DN Capital held on to the company despite initial difficulties having endured the bursting of the dot-com bubble and supported it for years to a successful exit
  • Auto1: Series A investment in 2013; according to Nenad Marovac, the most successful deal in the fund’s history. DN Capital remained on board for the long term and provided strategic support – the multi-billion Euro IPO followed in 2021 
  • Cognigy: $955m acquisition by NiCE in 2025, at the time Europe’s largest ever AI acquisition, having invested in 2019 at Series A long before the LLM hype

Why the German market plays a key role

Berlin is more than just a secondary location for DN Capital, it’s a critical European operations and investment hub. With the office having first opened in 2021 and Partner Gülsah Wilke joining to oversee German business since 2024, DN has focused much of its invesment attention on Germany – supporting some of Europe’s most significant outcomes:

  • Cognigy: AI platform for agentic customer service, acquired in 2025 in the largest European AI acquisition at the time
  • Mister Spex: online optician; early investment by DN Capital; supported until IPO in 2021
  • Numa: leading operator of digitally-enabled hotel experiences
  • AUTO1: Germany’s largest used car marketplace, Nenad led its series A in 2013 and AUTO1 listed in 2021

With targeted sourcing, in-depth operational support for portfolio companies and decades of nuanced local market understanding, DN Capital is building a pipeline for the next European technology leaders from Berlin. 

An optimistic outlook

Nenad Marovac sees potential improvements in Europe’s VC landscape in 2026. On the one hand, due to languishing economies, European policymakers are increasingly recognising the importance of strong startups to deliver growth – whether in the recommendations of the Draghi report or in improving the management of stock options

On the other hand, as frontier artificial intelligence models might – at least for the most part – be developed elsewhere, Marovac sees Europe’s tech talent and deep pool of enterprise customers as ideal ground for developing companies that work on the application layer of AI for enterprises.

Comments
Market Opportunity
Moonveil Logo
Moonveil Price(MORE)
$0.0006493
$0.0006493$0.0006493
-1.32%
USD
Moonveil (MORE) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

A whale that made a 141% profit on PUMP three days ago bought 321 million TRUMPs today, with a floating profit of $223,000.

A whale that made a 141% profit on PUMP three days ago bought 321 million TRUMPs today, with a floating profit of $223,000.

PANews reported on September 18th that according to Lookonchain monitoring, whale H56YMH sold 317 million PUMPs (worth approximately $2.53 million) at an average price of $0.008 three days ago, realizing a net profit of $1.48 million (a 141% return). Subsequently, eight hours ago, it purchased 321 million TRUMPs at an average price of $0.007835, resulting in unrealized profits of $223,000.
Share
PANews2025/09/18 10:36
Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves

Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves

The post Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves appeared on BitcoinEthereumNews.com. The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee, America’s Health Insurance Plans said Wednesday, Sept. 17, 2025. In this photo is a free flu and Covid-19 vaccine shots available sign, CVS, Queens, New York. (Photo by: Lindsey Nicholson/Universal Images Group via Getty Images) UCG/Universal Images Group via Getty Images The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee. The announcement by America’s Health Insurance Plans (AHIP), which includes CVS Health’s Aetna, Humana, Cigna, Centene and an array of Blue Cross and Blue Shield plans as members, comes ahead of the first meeting of the reconstituted Advisory Committee on Immunization Practices, which now has new members chosen by U.S. Health and Human Services Secretary Robert F. Kennedy Jr., a vaccine critic. “Health plans are committed to maintaining and ensuring affordable access to vaccines,” AHIP said in a statement Wednesday. “Health plan coverage decisions for immunizations are grounded in each plan’s ongoing, rigorous review of scientific and clinical evidence, and continual evaluation of multiple sources of data.” The move by AHIP is good news for millions of Americans at a time of year when they flock to drugstores, pharmacies, physician’s offices and outpatient clinics to get their seasonal flu and Covid shots. Kennedy’s changes to U.S. vaccine policy have created confusion across the country over whether certain vaccines long covered by insurance would continue to be. AHIP has now provided some clarity for millions of Americans. “Health plans will continue to cover all ACIP-recommended immunizations that were recommended as of September 1, 2025, including updated formulations of the COVID-19 and influenza vaccines, with no cost-sharing…
Share
BitcoinEthereumNews2025/09/18 03:11
Silver Price Crash Is Over “For Real This Time,” Analyst Predicts a Surge Back Above $90

Silver Price Crash Is Over “For Real This Time,” Analyst Predicts a Surge Back Above $90

Silver has been taking a beating lately, and the Silver price hasn’t exactly been acting like a safe haven. After running up into the highs, the whole move reversed
Share
Captainaltcoin2026/02/07 03:15